# Inflammation and Depression in People With HIV

> **NCT05849038** · PHASE2 · RECRUITING · sponsor: **Emory University** · enrollment: 60 (estimated)

## Conditions studied

- HIV
- Depression
- Anhedonia

## Interventions

- **DRUG:** Baricitinib
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05849038
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-11
- **Primary completion:** 2027-11
- **Final completion:** 2027-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05849038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05849038, "Inflammation and Depression in People With HIV". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05849038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*